(E)-2-amino-3-[1-[6-(2-amino-3-cyanospiro[5,6,7,8-tetrahydrocyclohepta[b]thiophene-4,3'-azetidine]-1'-yl)-5-cyano-2-methoxypyrimidin-4-yl]-2,5,6,7-tetrahydro-1,4-diazepin-3-yl]-3-chloro-N,N-dimethylprop-2-enamide;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine
C35H45ClFN11O2S — CID 177033351
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-2-amino-3-[1-[6-(2-amino-3-cyanospiro[5,6,7,8-tetrahydrocyclohepta[b]thiophene-4,3'-azetidine]-1'-yl)-5-cyano-2-methoxypyrimidin-4-yl]-2,5,6,7-tetrahydro-1,4-diazepin-3-yl]-3-chloro-N,N-dimethylprop-2-enamide;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine
(E)-2-amino-3-[1-[6-(2-amino-3-cyanospiro[5,6,7,8-tetrahydrocyclohepta[b]thiophene-4,3'-azetidine]-1'-yl)-5-cyano-2-methoxypyrimidin-4-yl]-2,5,6,7-tetrahydro-1,4-diazepin-3-yl]-3-chloro-N,N-dimethylprop-2-enamide;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine (PubChem CID 177033351) has the molecular formula C35H45ClFN11O2S and a molecular weight of 738.34 g/mol. Its IUPAC name is (E)-2-amino-3-[1-[6-(2-amino-3-cyanospiro[5,6,7,8-tetrahydrocyclohepta[b]thiophene-4,3'-azetidine]-1'-yl)-5-cyano-2-methoxypyrimidin-4-yl]-2,5,6,7-tetrahydro-1,4-diazepin-3-yl]-3-chloro-N,N-dimethylprop-2-enamide;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine.
Molecular Properties
| Compound Name | (E)-2-amino-3-[1-[6-(2-amino-3-cyanospiro[5,6,7,8-tetrahydrocyclohepta[b]thiophene-4,3'-azetidine]-1'-yl)-5-cyano-2-methoxypyrimidin-4-yl]-2,5,6,7-tetrahydro-1,4-diazepin-3-yl]-3-chloro-N,N-dimethylprop-2-enamide;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine |
|---|---|
| PubChem CID | 177033351 |
| Molecular Formula | C35H45ClFN11O2S |
| Molecular Weight | 738.34 g/mol |
| Exact Mass | 737.32 |
| IUPAC Name | (E)-2-amino-3-[1-[6-(2-amino-3-cyanospiro[5,6,7,8-tetrahydrocyclohepta[b]thiophene-4,3'-azetidine]-1'-yl)-5-cyano-2-methoxypyrimidin-4-yl]-2,5,6,7-tetrahydro-1,4-diazepin-3-yl]-3-chloro-N,N-dimethylprop-2-enamide;2-fluoro-2,3,5,6,7,8-hexahydro-1H-pyrrolizine |
| SMILES | COc1nc(N2CCCN=C(/C(Cl)=C(\N)C(=O)N(C)C)C2)c(C#N)c(N2CC3(CCCCc4sc(N)c(C#N)c43)C2)n1.FC1CC2CCCN2C1 |
| InChI | InChI=1S/C28H33ClN10O2S.C7H12FN/c1-37(2)26(40)22(32)21(29)18-13-38(10-6-9-34-18)24-17(12-31)25(36-27(35-24)41-3)39-14-28(15-39)8-5-4-7-19-20(28)16(11-30)23(33)42-19;8-6-4-7-2-1-3-9(7)5-6/h4-10,13-15,32-33H2,1-3H3;6-7H,1-5H2/b22-21+; |
| InChIKey | BTLFGUNADMSJJA-QUABFQRHSA-N |
| XLogP | 3.70 |
| TPSA | 177.02 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 51 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 738.34 |
| LogP ≤ 5 | 3.70 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177033351 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.